NDC11 82491002510
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 82491-0025-10 | 82491-0025 |
| 82491-025-10 | 82491-025 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LYTENAVA | BEVACIZUMAB-VIKG | Outlook Therapeutics, Inc. | 7f9a3014-b3d4-4943-a83a-92a77d8f947c | 2026-10-29 | Warnings, Adverse reactions | 82491-025-10 82491-025 82491002510 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.